Perficient: Drug Development

JANUARY 23, 2024

A few weeks back, I wrote about key trends that would impact the medical device world in 2024. This time around, I’m going to be counting down some 2024 resolutions for medical device marketers. One way is to lean into consumer quotes and testimonials, whether patients or clinical profiles. So how can you strike the balance?

Marketing 52

Marketing Testimonials Production Science 52

Agency IQ

JUNE 29, 2023

to provide notice and an opportunity for owners or consignees of the drug to appear before the Agency and introduce testimony prior to the destruction of their drug. OIG claims a review will be complete in 2024. The final rule will amend the administrative destruction provisions in 21 CFR 1.94

FDA 40

FDA Science Regulations Production 40

Agency IQ

SEPTEMBER 29, 2023

AgencyIQ November 27 DSCSA Technically goes into full effect While the FDA has technically extended enforcement of certain provisions under the Drug Supply Chain Security Act until November 2024, certain provisions of the law are still due to come into effect in late November. Review to take place within 21 days. to include devices.

FDA 40

FDA Science Regulations Production 40

Agency IQ

OCTOBER 27, 2023

and Annex 1 Conference Joel Welch December 18 RAPS RAPS Webcast: FDA Forecast: What’s Next for the FDA in 2024 AgencyIQ Speakers December 21 HL7 REMS Public Call PDUFA Dates expected in November and December PDUFA dates represent the expected date of a regulatory decision by the FDA on a New Drug Application or Biologics License Application.

FDA 40

FDA Science Regulations Production 40

Agency IQ

DECEMBER 1, 2023

and Annex 1 Conference Joel Welch December 12 AgencyIQ Looking ahead to 2024: Regulatory Forecast for the U.S. and Annex 1 Conference Joel Welch December 12 AgencyIQ Looking ahead to 2024: Regulatory Forecast for the U.S. Morgan Chase 42 nd Annual J.P.

FDA 40

FDA Science Regulations Production 40

Perficient: Drug Development

DECEMBER 18, 2024

React 19 has officially been released as a stable version on December 5, 2024. This update introduces amazing features that enhance the developer experience and application performance. If CourseWrapper takes longer to receive its data, CourseList and Testimonials cannot render until CourseWrapper completes.

Testimonials 52

Testimonials Production 52

Conversations in Drug Development Trends

MARCH 11, 2025

Current CAR T Landscape & Growth Trends CAR T therapies are witnessing an impressive surge of growth, with 2024 marking a record number of these studies. Tahseen Mozaffar of UC Irvine in an on-demand webinar, Expanding CAR T Beyond Oncology: Medical, Operational & Practical Considerations.

Clinical Trials 40

Clinical Trials Therapies Trials Treatment 40